- Joined
- Jan 24, 2004
- Messages
- 1,333
- Reaction score
- 12
Hi,
Nice 3 domains. I tried to buy amniotic .com to complete the set...but they wanted a "solid" 6 figures for it.
amniotic .net
amniotic .org
amniotic .biz
Enom: Push
BIN ~ All 3 domains: $2400
Offers ~ Start: $800
Post offer or post "sold" to claim at BIN.
Thanks for looking.
Peace,
Dan
____
Info on this subject:
Catholic Bishops Urge Senate to Reject Embryonic Stem Cell Research Funds
by Steven Ertelt
LifeNews.com Editor
April 5, 2007
Washington, DC (LifeNews.com) -- The nation's Catholic bishops are calling on the Senate to oppose a bill next week that would force taxpayers to fund embryonic stem cell research that involves the destruction of human life. The Senate is expected to vote on that measure and an alternative bill on April 11 after a debate on both bills the day before.
Cardinal Justin Rigali the Archbishop of Philadelphia and chairman of the pro-life office at the United States Conference of Catholic Bishops, sent a letter to the Senate Wednesday.
âWith enactment of such legislation, federal law would for the first time force taxpayers to encourage deliberate attacks on innocent human life in the name of medical progress,â the Cardinal said, according to a copy provided to LifeNews.com.
Rigali emphasized that the stem cell issue is not a matter of supporting versus opposing scientific or medical progress.
âThe question is whether our technical progress is guided by an equally advanced sense of the dignity of each and every human life, so our technology becomes a servant to humanity and not our cruel master,â the Cardinal wrote.
Quoting Pope Benedict XVI, he said that "research that relies on âthe planned suppression of human beings who already exist, even if they have not yet been born,â is ânot truly at the service of humanity.ââ
The Catholic leader also pointed out the problems associated with the controversial research and said that senators, if they're truly concerned about the best interests of patients, would look to alternatives.
âOn a practical level, embryonic stem cell research has been as disappointing in its results as it has been divisive to our society," Rigali wrote.
He explained that âProblems such as uncontrollable growth and tumor formation have forced researchers to conclude that it may take a decade or more of very expensive research even to determine whether embryonic stem cells may someday be used to treat a human condition.â
âIt seems virtually every byproduct of live birth -- amniotic fluid, amniotic membrane, placenta, cord blood, and the tissue of the umbilical cord itself -- contains stem cells that may rival embryonic stem cells in their flexibility,â he added, talking about adult stem cell research.
The alternative bill -- sponsored by Republican Sens. Norm Coleman of Minnesota and Johnny Isakson of Georgia -- would encourage federal funding for research into new ways to obtain different kinds of stem cells, without harming human embryos in the process.
The bill (S. 30) includes a proposal to study the feasibility of banking amniotic and placental stem cells, modeled on the banking of bone marrow and cord blood stem cells that have saved the lives of patients with dozens of conditions.
Rigali said that Senators should consider that bill instead of S. 5, the funding measure.
âUnlike S. 5, it gives priority to research that promises genuine benefits for patients in the short term -- a priority that supporters of S. 5 have neglected in their zeal for speculative embryo research,â the Cardinal wrote.
Last year, the House and Senate approved the embryonic funding bills and President Bush vetoed the final version of the measure. The House failed to override the veto and the Senate didn't vote but was just short of the two-thirds vote needed to override.
The November elections gave funding backers more votes and the Senate appears to have enough votes to override a veto but the House is still short -- it already voted on its version of the new bill, which it approved on a 253-174 vote in January.
Once Congress sends the funding bill to the president, Bush has promised to veto the measure. The Senate would then take up an override veto and, if successful, the House would try to follow suit.
Full Article: http://www.lifenews.com/bio2062.html
_____
Media Continues Cover-Up of Alternative, Ethical Stem Cell Sources
As stem-cell researcher Malcolm Alison of the University of London told the Daily Mail, the amniotic cells "appear to be at least as malleable as embryonic stem cells but without all the ethical baggage."
Amniotic stem cells may be the most easily differentiated of all--as well as among the easiest to extract in large amounts. Indeed, they are routinely recovered with a hypodermic needle during amniocentesis. While it's widely believed that this procedure slightly increases the chance of miscarriage, a sizable study last November of 35,000 women who underwent mid-trimester testing found "no significant difference in loss rates between those undergoing amniocentesis and those not undergoing amniocentesis."
THERE ARE OVER four million births each year in the United States, yet Atala calculates that merely 100,000 amniotic stem cell specimens could supply 99 percent of the U.S. population's needs for perfect matches for transplants. (That assumes a perfect match is even needed.) About 700,000 amniocentesis procedures are performed in the United States and Western Europe each year
Full Article: http://www.lifenews.com/bio1982.html
___________
Amniotic cells show real benefits
Tuesday, January 23, 2007
I am legally blind as a result of juvenile diabetes, which I've been suffering from for 48 years. I am a cancer survivor and kidney failure survivor.
I am alive today because of breakthroughs in medical science that allowed loving individuals to donate the kidney and pancreas that help keep me alive. In other words, if anyone should be for groundbreaking stem cell research, I should be. And I am.
I fully support using stem cells from the amniotic fluid in placentas to combat disease. In fact, according to Wake Forest researcher Anthony Atala, a bank of 100,000 of these amniotic cells could supply 99 percent of the U.S. population with perfect genetic matches for transplantation. Amniotic stem cells also do not appear to produce tumors--a major drawback of embryonic stem cells.
In the editorial "Stem cells," (Jan. 11), The Patriot-News shows that it has been hoodwinked by the biotech industry and some misinformed disease advocacy groups. Federal funding for embryonic stem cell research just means pouring money down a disastrous dark hole. The smart money is on amniotic and adult stem cell research.
Nice 3 domains. I tried to buy amniotic .com to complete the set...but they wanted a "solid" 6 figures for it.
amniotic .net
amniotic .org
amniotic .biz
Enom: Push
BIN ~ All 3 domains: $2400
Offers ~ Start: $800
Post offer or post "sold" to claim at BIN.
Thanks for looking.
Peace,
Dan
____
Info on this subject:
Catholic Bishops Urge Senate to Reject Embryonic Stem Cell Research Funds
by Steven Ertelt
LifeNews.com Editor
April 5, 2007
Washington, DC (LifeNews.com) -- The nation's Catholic bishops are calling on the Senate to oppose a bill next week that would force taxpayers to fund embryonic stem cell research that involves the destruction of human life. The Senate is expected to vote on that measure and an alternative bill on April 11 after a debate on both bills the day before.
Cardinal Justin Rigali the Archbishop of Philadelphia and chairman of the pro-life office at the United States Conference of Catholic Bishops, sent a letter to the Senate Wednesday.
âWith enactment of such legislation, federal law would for the first time force taxpayers to encourage deliberate attacks on innocent human life in the name of medical progress,â the Cardinal said, according to a copy provided to LifeNews.com.
Rigali emphasized that the stem cell issue is not a matter of supporting versus opposing scientific or medical progress.
âThe question is whether our technical progress is guided by an equally advanced sense of the dignity of each and every human life, so our technology becomes a servant to humanity and not our cruel master,â the Cardinal wrote.
Quoting Pope Benedict XVI, he said that "research that relies on âthe planned suppression of human beings who already exist, even if they have not yet been born,â is ânot truly at the service of humanity.ââ
The Catholic leader also pointed out the problems associated with the controversial research and said that senators, if they're truly concerned about the best interests of patients, would look to alternatives.
âOn a practical level, embryonic stem cell research has been as disappointing in its results as it has been divisive to our society," Rigali wrote.
He explained that âProblems such as uncontrollable growth and tumor formation have forced researchers to conclude that it may take a decade or more of very expensive research even to determine whether embryonic stem cells may someday be used to treat a human condition.â
âIt seems virtually every byproduct of live birth -- amniotic fluid, amniotic membrane, placenta, cord blood, and the tissue of the umbilical cord itself -- contains stem cells that may rival embryonic stem cells in their flexibility,â he added, talking about adult stem cell research.
The alternative bill -- sponsored by Republican Sens. Norm Coleman of Minnesota and Johnny Isakson of Georgia -- would encourage federal funding for research into new ways to obtain different kinds of stem cells, without harming human embryos in the process.
The bill (S. 30) includes a proposal to study the feasibility of banking amniotic and placental stem cells, modeled on the banking of bone marrow and cord blood stem cells that have saved the lives of patients with dozens of conditions.
Rigali said that Senators should consider that bill instead of S. 5, the funding measure.
âUnlike S. 5, it gives priority to research that promises genuine benefits for patients in the short term -- a priority that supporters of S. 5 have neglected in their zeal for speculative embryo research,â the Cardinal wrote.
Last year, the House and Senate approved the embryonic funding bills and President Bush vetoed the final version of the measure. The House failed to override the veto and the Senate didn't vote but was just short of the two-thirds vote needed to override.
The November elections gave funding backers more votes and the Senate appears to have enough votes to override a veto but the House is still short -- it already voted on its version of the new bill, which it approved on a 253-174 vote in January.
Once Congress sends the funding bill to the president, Bush has promised to veto the measure. The Senate would then take up an override veto and, if successful, the House would try to follow suit.
Full Article: http://www.lifenews.com/bio2062.html
_____
Media Continues Cover-Up of Alternative, Ethical Stem Cell Sources
As stem-cell researcher Malcolm Alison of the University of London told the Daily Mail, the amniotic cells "appear to be at least as malleable as embryonic stem cells but without all the ethical baggage."
Amniotic stem cells may be the most easily differentiated of all--as well as among the easiest to extract in large amounts. Indeed, they are routinely recovered with a hypodermic needle during amniocentesis. While it's widely believed that this procedure slightly increases the chance of miscarriage, a sizable study last November of 35,000 women who underwent mid-trimester testing found "no significant difference in loss rates between those undergoing amniocentesis and those not undergoing amniocentesis."
THERE ARE OVER four million births each year in the United States, yet Atala calculates that merely 100,000 amniotic stem cell specimens could supply 99 percent of the U.S. population's needs for perfect matches for transplants. (That assumes a perfect match is even needed.) About 700,000 amniocentesis procedures are performed in the United States and Western Europe each year
Full Article: http://www.lifenews.com/bio1982.html
___________
Amniotic cells show real benefits
Tuesday, January 23, 2007
I am legally blind as a result of juvenile diabetes, which I've been suffering from for 48 years. I am a cancer survivor and kidney failure survivor.
I am alive today because of breakthroughs in medical science that allowed loving individuals to donate the kidney and pancreas that help keep me alive. In other words, if anyone should be for groundbreaking stem cell research, I should be. And I am.
I fully support using stem cells from the amniotic fluid in placentas to combat disease. In fact, according to Wake Forest researcher Anthony Atala, a bank of 100,000 of these amniotic cells could supply 99 percent of the U.S. population with perfect genetic matches for transplantation. Amniotic stem cells also do not appear to produce tumors--a major drawback of embryonic stem cells.
In the editorial "Stem cells," (Jan. 11), The Patriot-News shows that it has been hoodwinked by the biotech industry and some misinformed disease advocacy groups. Federal funding for embryonic stem cell research just means pouring money down a disastrous dark hole. The smart money is on amniotic and adult stem cell research.
